Fulcrum Asset Management LLP
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1353395
LONDON, X0
Position in INDV
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$8,206
New position
Shares Held
200
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#288
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fulcrum Asset Management LLP holds $360,293 across 9 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,114 | $223,772 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
4,400 | $79,024 | |
| 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,750 | $35,315 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
200 | $8,206 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
138 | $6,523 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
70 | $3,255 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
40 | $1,448 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
44 | $1,381 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,206 | 200 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||